$10.73
+0.21 (+2.00%)
Open$11.00
Previous Close$10.52
Day High$11.80
Day Low$10.62
52W High$11.69
52W Low$4.32
Volume—
Avg Volume395.2K
Market Cap597.28M
P/E Ratio—
EPS$-4.53
SectorBiotechnology
Analyst Ratings
Buy
12 analysts
Price Target
+26.0% upside
Current
$10.73
$10.73
Target
$13.52
$13.52
$9.22
$13.52 avg
$14.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 10.10M | 17.90M | 162.70M |
| Net Income | -254,550,026 | -405,980,902 | -26,550,677 |
| Profit Margin | -2,520.6% | -2,394.5% | -16.3% |
| EBITDA | -223,243,505 | -375,830,816 | -39,466,979 |
| Free Cash Flow | — | — | -19,760,246 |
| Rev Growth | -43.6% | -43.6% | +13.5% |
| Debt/Equity | — | — | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |